The reduction of the PGC-1α axis during cardiac dysfunction and PD, along with its ability to enhance energy production and reduce oxidative stress, highlights its potential as a target for preventing and treating these diseases [195,199]. This evidence concerns the gene PPARGC1A and Parkinson disease.